340B Report
340B Report is a niche news portal founded in 2020 that covers and analyzes the U.S. 340B drug discount program, serving healthcare stakeholders, policy professionals, and industry participants tracking regulatory and operational developments.
- Company typePrivate
- Founded2020
- HeadquartersVienna, United States
- Headcount1–10
- GTM typeB2B
- OfferingDigital Commerce or Content
What 340B Report does
340B Report is a for-profit private news portal and information service that covers and analyzes the 340B drug discount program, a U.S. federal drug pricing mechanism. Founded in 2020 and headquartered in Vienna, Virginia, the company operates as a niche B2B media outlet serving stakeholders who monitor 340B program developments, likely including hospitals, federally qualified health centers, contract pharmacies, drug manufacturers, and policy professionals. The publication provides editorial coverage of regulatory, legislative, and operational developments affecting the 340B program.
The company's product is a web-based news and analysis portal accessible at 340breport.com. No detailed product portfolio, technology stack, or proprietary platform features are disclosed in the source data; the site appears to function as a content publication rather than a software or data product. No app, API, SDK, or integration offerings are documented. The firm's scale is small, with 1-10 employees reported.
No pricing model, revenue mechanics, or go-to-market approach are disclosed in the available data. The absence of funding round information, ownership details, or financial disclosures limits visibility into the business model. The firm operates as an unbacked or minimally capitalized micro-media entity based on the available firmographic data.
340B Report firmographics
Firmographics- Name
- 340B Report
- Website
- https://340breport.com
- Company type
- Private
- Founded year
- 2020
- Headcount range
- 1–10 employees
- Short description
- 340B Report is a niche news portal founded in 2020 that covers and analyzes the U.S. 340B drug discount program, serving healthcare stakeholders, policy professionals, and industry participants tracking regulatory and operational developments.
- Ownership category
- akta.pro rank
340B Report industry classification
Industry- Product category
- Healthcare Industry News and Policy Analysis
- NAICS
- Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- 340B Program Administration & Support (HLAEAKAJ)
- akta.pro secondary industry
- Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price) (HLAIAKAE)
Keywords
Where 340B Report is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- United States
- HQ region
- North America
Markets served
340B Report business model
Business model- GTM type
- B2B
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
340B Report product offering
Product offeringCore offering
340B Report is a news portal that covers and analyzes the 340B drug discount program. The publication delivers news, analysis, and intelligence on the federal 340B Drug Pricing Program, which requires drug manufacturers to provide outpatient drugs at discounted prices to eligible healthcare organizations serving low-income patients.
Product overview
340B Report is a publication and information service covering the 340B drug pricing program. No product portfolio or service offerings were available in the source data.
Differentiator
Problem solved
Functional benefit
Products and services
- 340B Report News & Analysis
Companies that use 340B Report
Customer profileIdeal customer profiles1 record
340B Report technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
340B Report partnerships and signals
Strategic signalRecent moves1 record
340B Report competitors and assessment
Company assessmentBroad incumbents
- STAT News: Major health and medicine news outlet covering pharma, policy, and drug pricing. Comparable as a health-focused news brand with overlapping audience among healthcare executives and policy professionals.
- Inside Health Policy: Subscription news service covering federal health policy including drug pricing programs. Comparable in serving policy professionals and lobbyists tracking 340B-related rulemaking.
- Covering Health (Politico Pro): Subscription policy intelligence service from Politico covering federal healthcare regulation. Comparable as a higher-resource policy news product serving the same healthcare policy audience.
- AIS Health (MMIT): Long-established healthcare industry news and data business covering payer, PBM, and pharmacy benefit topics including 340B. Comparable as a broader, more resource-rich incumbent in healthcare business media.
Direct peers
- Drug Topics: Trade publication for pharmacists covering pharmacy practice, drug news, and policy issues including 340B-related topics. Comparable in audience and editorial category.
- Drug Channels: An independent newsletter and resource covering the pharmaceutical supply chain, drug pricing, PBM economics, and the 340B program. Direct overlap with 340B Report's coverage area and target audience of industry executives.
- Pharmacy Times: A pharmacy trade publication covering retail and clinical pharmacy practice, drug pricing, and policy. Comparable as a trade media outlet serving pharmacy and drug-pricing stakeholders, including those affected by 340B.
- Becker's Hospital Review: Healthcare business news outlet frequently covering hospital finance, drug pricing, and the 340B program. Comparable trade media business serving hospital and health system executives.
Others
- Drug Discovery & Development: Pharmaceutical industry trade publication covering drug development and commercialization. Comparable as adjacent trade media reaching pharmaceutical manufacturer stakeholders involved in 340B.
- 340B Health: Association representing hospitals participating in the 340B program. Not a media peer, but an influential stakeholder in the same ecosystem whose communications and advocacy shape the audience 340B Report covers.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights3 records
Customer concentration
340B Report social profiles
Digital presence340B Report financial estimates
Financial estimateRevenue estimate
Valuation estimate
340B Report leadership team
Management profileNumber of profiles
340B Report funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
340B Report M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 340B Report
What does 340B Report do?
340B Report is a news portal that covers and analyzes the 340B drug discount program. The publication delivers news, analysis, and intelligence on the federal 340B Drug Pricing Program, which requires drug manufacturers to provide outpatient drugs at discounted prices to eligible healthcare organizations serving low-income patients.
When was 340B Report founded?
340B Report was founded in 2020. It employs 1 to 10 people.
Where is 340B Report based?
340B Report is headquartered in Vienna, United States, in the North America region.
Who are 340B Report's main competitors?
Broad incumbents on record are STAT News, Inside Health Policy, Covering Health (Politico Pro) and AIS Health (MMIT). Direct peers are Drug Topics, Drug Channels, Pharmacy Times and Becker's Hospital Review. Others are Drug Discovery & Development and 340B Health.
Does 340B Report have an API?
No public API is recorded for 340B Report.
What industry is 340B Report in?
340B Report's product category is Healthcare Industry News and Policy Analysis. Its primary akta.pro industry code is HLAEAKAJ, 340B Program Administration & Support, with a secondary code of HLAIAKAE, Government Pricing & Compliance (Medicare/Medicaid/340B/AMP/Best Price). Its NAICS code is 524292 and its SIC code is 8000.